反应 #1857574

ord-2f407bfd54fa48fb9962006b64230ff4

反应方程式

O=C1CCC(=O)N1Cl
N-chlorosuccinimide
CC(C)(C)OC(=O)N1CCC(c2nc(C=NO)cs2)CC1
tert-butyl 4-{4-[(hydroxyimino)methyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate
C=Cc1ccccc1OCC1CCCCC1
1-(cyclohexylmethoxy)-2-vinylbenzene
O=C([O-])O.[K+]
potassium hydrogencarbonate
CC(C)(C)OC(=O)N1CCC(c2nc(C3=NOC(c4ccccc4OCC4CCCCC4)C3)cs2)CC1
tert-Butyl 4-(4-{5-[2-(cyclohexylmethoxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidine-1-carboxylate

反应条件

温度
60°CELSIUS
详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    萃取extracted with ethyl acetate
  2. 2
    干燥The organic extracts were dried over sodium sulphate
  3. 3
    浓缩concentrated under reduced pressure
  4. 4
    其他The residue was purified by chromatography

实验过程

To a solution of tert-butyl 4-{4-[(hydroxyimino)methyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate (2.90 g) and 1-(cyclohexylmethoxy)-2-vinylbenzene (2.40 g) in ethyl acetate (300 ml) were added, at room temperature, potassium hydrogencarbonate (4.60 g) and N-chlorosuccinimide (1.48 g), and then one drop of water. The reaction mixture was stirred at 60° C. for 6 h, then admixed with ethyl acetate and water and extracted with ethyl acetate. The organic extracts were dried over sodium sulphate and concentrated under reduced pressure. The residue was purified by chromatography. This gave tert-butyl 4-(4-{5-[2-(cyclohexylmethoxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidine-1-carboxylate (3.40 g).

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US09247748B2uspto-grants-2016_02